Back
  1. Home
  3. Detailed Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
Efficacy and tolerance of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone
Reginster, Jean-Yves; Treves, R; Renier, JC et al.
1993 • In Calcified Tissue International, 52 (S2), p. 82
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/157446
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Efficacy and tolerance of a new formulation of oral tiludronate (TABLET) in the treatment of Paget's disease of bone.pdf
Publisher postprint (112.62 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
General & internal medicine
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Treves, R
Renier, JC
Amor, B
Sany, J
Ethgen, D
Franchimont, P
Language :
English
Title :
Efficacy and tolerance of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone
Publication date :
1993
Event name :
Clinical Disorders of Bone and Mineral Metabolism 5th International Symposium
Event place :
Detroit, Michigan, United States
Event date :
Du 16 mai 1993 au 21 mai 1993
Audience :
International
Journal title :
Calcified Tissue International
ISSN :
0171-967X
eISSN :
1432-0827
Publisher :
Springer, New York, United States - New York
Volume :
52
Issue :
S2
Pages :
82
Peer review/Selection committee :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 October 2013

Statistics

Number of views
55 (2 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi